Analyst Consensus ?
ConsensusHold23 ratings
Bullish1356.5%
Neutral730.4%
Bearish313.1%
FN2 Earnings Intelligence
Roper Technologies, Inc. analyst ratings
Roper Technologies, Inc. (ROP) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$408.07Previous close
$355Low
$516.08Average
$665High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Underweight | Underweight | Maintain | Jul 29, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 24, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Barclays | Underweight | Underweight | Maintain | Apr 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 29, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jan 28, 2026 |
| Stifel | Hold | Buy | Downgrade | Jan 28, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Jan 28, 2026 |
| Mizuho | Underperform | Underperform | Maintain | Jan 28, 2026 |
| Citigroup | Buy | Buy | Maintain | Jan 28, 2026 |
| Argus Research | Hold | Buy | Downgrade | Jan 28, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 5, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 24, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 24, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 13, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Jan 22, 2024 |
| Bernstein | Outperform | Market Perform | Upgrade | May 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jul 26, 2022 |
| Stephens & Co. | Overweight | Overweight | Maintain | Apr 30, 2019 |
| Argus | Buy | Buy | Maintain | Aug 2, 2018 |
| Canaccord Genuity | Hold | Hold | Maintain | Feb 5, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 2, 2016 |
Named analyst price targets
Upside is calculated against the persisted previous close $408.07. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Deane Dray | $417 | $370.27 | +2.2% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $480 | $355.12 | +17.6% | Jul 24, 2026 |
| Piper Sandler | Clarke Jeffries | $526 | $355.12 | +28.9% | Jul 24, 2026 |
| Mizuho Securities | Analyst unavailable | $355 | $362.84 | -13.0% | Jul 21, 2026 |
| BMO Capital | Daniel Jester | $393 | $355.94 | -3.7% | Jul 10, 2026 |
| RBC Capital | Analyst unavailable | $407 | $363.76 | -0.3% | Apr 24, 2026 |
| Robert W. Baird | Analyst unavailable | $470 | $363.76 | +15.2% | Apr 24, 2026 |
| Piper Sandler | Analyst unavailable | $540 | $363.76 | +32.3% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $373 | $363.76 | -8.6% | Apr 24, 2026 |
| Goldman Sachs | Analyst unavailable | $440 | $360.37 | +7.8% | Jan 29, 2026 |
| RBC Capital | Analyst unavailable | $398 | $360.66 | -2.5% | Jan 28, 2026 |
| Mizuho Securities | Analyst unavailable | $365 | $360.98 | -10.6% | Jan 28, 2026 |
| Robert W. Baird | Analyst unavailable | $550 | $358.34 | +34.8% | Jan 28, 2026 |
| Jefferies | Analyst unavailable | $500 | $369.27 | +22.5% | Jan 28, 2026 |
| Barclays | Analyst unavailable | $409 | $369.27 | +0.2% | Jan 28, 2026 |
| Stifel Nicolaus | Analyst unavailable | $385 | $369.27 | -5.7% | Jan 27, 2026 |
| Truist Financial | Terry Tillman | $550 | $369.27 | +34.8% | Jan 27, 2026 |
| Melius Research | Scott Davis | $479 | $355.89 | +17.4% | Jan 27, 2026 |
| Oppenheimer | Analyst unavailable | $525 | $407.48 | +28.7% | Jan 23, 2026 |
| Piper Sandler | Clarke Jeffries | $530 | $432.39 | +29.9% | Jan 13, 2026 |
| Jefferies | Analyst unavailable | $600 | $430.77 | +47.0% | Jan 5, 2026 |
| Mizuho Securities | Analyst unavailable | $419 | $434.54 | +2.7% | Jan 5, 2026 |
| Barclays | Analyst unavailable | $475 | $445.89 | +16.4% | Dec 4, 2025 |
| Piper Sandler | Clarke Jeffries | $600 | $444.78 | +47.0% | Nov 19, 2025 |
| Barclays | Analyst unavailable | $506 | $470.18 | +24.0% | Oct 27, 2025 |
| RBC Capital | Analyst unavailable | $539 | $478.8 | +32.1% | Oct 27, 2025 |
| Truist Financial | Analyst unavailable | $650 | $479.85 | +59.3% | Oct 24, 2025 |
| Stifel Nicolaus | Analyst unavailable | $550 | $479.96 | +34.8% | Oct 24, 2025 |
| RBC Capital | Deane Dray | $644 | $479.96 | +57.8% | Oct 24, 2025 |
| Robert W. Baird | Analyst unavailable | $592 | $479.96 | +45.1% | Oct 24, 2025 |
| Raymond James | Brian Gesuale | $575 | $479.51 | +40.9% | Oct 24, 2025 |
| Jefferies | Analyst unavailable | $650 | $479.96 | +59.3% | Oct 23, 2025 |
| Oppenheimer | Ken Wong | $570 | $479.96 | +39.7% | Oct 23, 2025 |
| Mizuho Securities | Brett Linzey | $510 | $500.08 | +25.0% | Oct 17, 2025 |
| Barclays | Julian Mitchell | $550 | $498.69 | +34.8% | Oct 1, 2025 |
| Mizuho Securities | Brett Linzey | $600 | $582.88 | +47.0% | May 16, 2025 |
| Oppenheimer | Christopher Glynn | $640 | $557.7 | +56.8% | Apr 28, 2025 |
| Stifel Nicolaus | Analyst unavailable | $685 | $582.71 | +67.9% | Mar 26, 2025 |
| Robert W. Baird | Joe Vruwink | $665 | $575.65 | +63.0% | Jan 31, 2025 |
| Truist Financial | Terry Tillman | $665 | $542.94 | +63.0% | Oct 24, 2024 |
| Robert W. Baird | Richard Eastman | $652 | $542.94 | +59.8% | Oct 24, 2024 |
| RBC Capital | Deane Dray | $666 | $542.94 | +63.2% | Oct 24, 2024 |
| Robert W. Baird | Joe Vruwink | $635 | $531.97 | +55.6% | Jul 25, 2024 |
| Barclays | Julian Mitchell | $625 | $550.47 | +53.2% | Jul 10, 2024 |
| Argus Research | John Eade | $575 | $511.46 | +40.9% | Apr 30, 2024 |
| Wolfe Research | Brad Hewitt | $625 | $543.01 | +53.2% | Apr 8, 2024 |
| Oppenheimer | Christopher Glynn | $650 | $556.38 | +59.3% | Mar 22, 2024 |
| Goldman Sachs | Analyst unavailable | $468 | $429.25 | +14.7% | Dec 15, 2022 |
| RBC Capital | Analyst unavailable | $565 | $472.01 | +38.5% | Apr 27, 2022 |
| Cowen & Co. | Joseph C Giordano | $520 | $487.88 | +27.4% | Jul 26, 2021 |
| Oppenheimer | Christopher Glynn | $560 | $494.71 | +37.2% | Jul 23, 2021 |
Track every rating change on ROP the moment it posts. Free to start.
Start free